Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v7-EN
Language English English
Date Updated 2023-10-14 2023-10-11
Drug Identification Number 02522268 02522268
Brand name LIDOCAINE HYDROCHLORIDE INJECTION LIDOCAINE HYDROCHLORIDE INJECTION
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION LIDOCAINE HYDROCHLORIDE INJECTION
Company Name LABORATOIRE AGUETTANT LABORATOIRE AGUETTANT
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 5 mL 10 x 5 mL
ATC code C01BB C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-09-28 2023-09-28
Actual start date 2023-10-06 2023-10-06
Estimated end date 2023-10-16 2023-10-16
Actual end date 2023-10-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delay in receiving product Delay in receiving product
Health Canada comments